M. Romagnoli (Forli, Italy), C. Taille (Paris, France)
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
H. Iwamoto, J. Gao, J. Koskela, H. Kobayashi, T. Laitinen, W. Mazur (Helsinki, Turku, Finland; Hiroshima, Tokorozawa, Japan)
|    |
The elderly subjects with asthma (ELSA) study. Asthma in subjects ≥65 yrs and its overlap with COPD
M. Milanese, A. Corsico, N. Scichilone, F. Di Marco (Savona, Pavia, Palermo, Milano, Italy)
| |
High prevalence of exercise-induced laryngeal obstruction in athletes with respiratory symptoms
E. W. Nielsen, J. Hull, V. Backer (Copenhagen, Denmark; London, United Kingdom)
| |
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
M. Latorre, F. Novelli, C. Baldini, E. Bacci, V. Seccia, S. Cianchetti, S. Bombardieri, P. L. Paggiaro (Pisa, Italy)
| |
Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test
H. Abtahi, S. Peiman (Tehran, Islamic Republic Of Iran)
| |
Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Z. Mironova, V. Trofimov, M. Dubina, V. Belash, A. Ulitina (Saint-Petersburg, Russian Federation)
| |
Importance of inhalation device in asthma and COPD: A consensus using Delphi
V. Ninane, G. Brusselle, R. Louis, L. Dupont, G. Liistro, W. De Backer, M. Shlesser, W. Vincken (Brussels, Gent, Liège, Leuven, Edegem, Belgium; Luxembourg, Luxembourg)
| |
Evidence of variation to drive quality improvement: The NHS atlas of variation in respiratory healthcare
M. Kearney, A. Moger, B. Thompson, J. Clarke, K. Holton, R. Winter, S. Hill (London, Cambridge, United Kingdom)
| |